Medical Research Commercialisation Fund

The Medical Research Commercialisation Fund (MRCF) is a life science investment fund managed by Brandon Capital Partners, focusing on early-stage biomedical discoveries in Australia and New Zealand. It collaborates with over 50 medical research institutes and hospitals to support the development and commercialisation of new therapies. The fund has invested in more than 50 start-up companies to date, most of which were founded by the MRCF. In 2022, MRCF was renamed Brandon BioCatalyst to better reflect its mission and growth.

Visit website ↗